Nature May 5, 2023
By Amy Abernethy

Real-world data reflect the diversity and lived experiences of individuals and so should be a central pillar of clinical research and care.

The key to the value of RWD will be scientific consensus about how to rigorously analyze and draw conclusions from what are currently novel data sources. This consensus is developing steadily, driven in large part by scientific guidance from regulatory authorities. Since 2021, a stream of guidance documents has outlined the US Food and Drug Administration (FDA) thinking on crucial scientific issues...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
Reevaluating Data Platforms In The Age Of AI
AI Is Nothing Without An AI-Ready Data Strategy
hc1 Acquires Lab Expert Accumen to Expand Data-Driven Lab Insights
Big Data Unicorn Innovaccer’s Latest Report Indicates 87% Of Healthcare Providers Want AI
The Inseparable Triad: Why Cloud Migration Is Essential For Data And AI Strategies

Share This Article